Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
biotech
boston blog main
boston top stories
cancer
5
×
clinical trials
5
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
deals
investing
pfizer
biotech ipos
bridgebio
cancer drugs
cell therapy
eli lilly
What
bio
roundup
cancer
drug
advantages
alliance
american
annual
appetite
ash
bar
black
blood
borne
bread
brings
bristol
butter
buy
buyout
calls
cancers
cash
changing
color
conference
crispr
days
despite
diabetes
diamond’s
diego
drugs
eli
expect
family
gamble
gathering
giant
grabbed
Language
unset
Current search:
amgen
×
" clinical trials "
×
cancer
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More